Agarwal, Roshan <br/><br/>
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Jul 2010 
 - 2020-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2010.03.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Treatment Outcome<br/>Gemcitabine